FR970M - - Google Patents
Info
- Publication number
- FR970M FR970M FR837319A FR837319A FR970M FR 970 M FR970 M FR 970M FR 837319 A FR837319 A FR 837319A FR 837319 A FR837319 A FR 837319A FR 970 M FR970 M FR 970M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR837319A FR970M (no) | 1958-11-04 | 1960-08-31 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB35428/58A GB870286A (en) | 1958-11-04 | 1958-11-04 | Improvements in or relating to 6-methyl-3-oxo-í~-steroid compounds |
| FR809052A FR1333711A (fr) | 1958-11-04 | 1959-11-02 | Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes |
| FR837319A FR970M (no) | 1958-11-04 | 1960-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR970M true FR970M (no) | 1961-12-04 |
Family
ID=10377599
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR809052A Expired FR1333711A (fr) | 1958-11-04 | 1959-11-02 | Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes |
| FR837319A Active FR970M (no) | 1958-11-04 | 1960-08-31 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR809052A Expired FR1333711A (fr) | 1958-11-04 | 1959-11-02 | Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3356573A (no) |
| BE (1) | BE584312A (no) |
| CH (1) | CH379493A (no) |
| DE (1) | DE1120446B (no) |
| FR (2) | FR1333711A (no) |
| GB (1) | GB870286A (no) |
| MY (1) | MY6400075A (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1210819B (de) * | 1962-03-23 | 1966-02-17 | Ayerst Mckenna & Harrison | Verfahren zur Herstellung von in 17alpha-Stellung alkylierten Pregnanderivaten |
| DE1201342B (de) * | 1963-03-05 | 1965-09-23 | Olin Mathieson | Verfahren zur Herstellung von Steroiden |
| US4370321A (en) * | 1976-09-01 | 1983-01-25 | Mead Johnson And Company | Progestational adjuvant therapy |
| US4346037A (en) * | 1981-07-10 | 1982-08-24 | The Upjohn Company | Base catalyzed acylation with enol esters |
| US5338732A (en) * | 1991-06-18 | 1994-08-16 | Bristol-Myers Squibb Company | Megestrol acetate formulation |
| CN1429104A (zh) * | 1998-03-11 | 2003-07-09 | 内部研究股份有限公司 | 5型和3型17β－羟基类固醇脱氢酶的抑制剂及其用法 |
| US6268356B1 (en) | 1998-04-20 | 2001-07-31 | Pharmaceutical Resources, Inc. | Flocculated suspension of megestrol acetate |
| US6028065A (en) * | 1998-04-20 | 2000-02-22 | Pharmaceutical Resources, Inc. | Flocculated suspension of megestrol acetate |
| US6656505B2 (en) | 2000-07-21 | 2003-12-02 | Alpharma Uspd Inc. | Method for forming an aqueous flocculated suspension |
| US20030198679A1 (en) * | 2000-11-08 | 2003-10-23 | Kundu Subhas C. | Flocculated pharmaceutical suspensions and methods for actives |
| CN106109435B (zh) * | 2016-07-09 | 2018-11-06 | 南京臣功制药股份有限公司 | 一种醋酸甲地孕酮胶囊及其制备方法 |
| CN106137993B (zh) * | 2016-08-09 | 2018-11-09 | 南京臣功制药股份有限公司 | 一种醋酸甲地孕酮分散片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2311102A (en) * | 1940-02-20 | 1943-02-16 | Ciba Pharm Prod Inc | Doubly unsaturated ketones and process of making same |
| CH236309A (de) * | 1940-02-20 | 1945-01-31 | Chem Ind Basel | Verfahren zur Darstellung eines ,ss; , -zweifach ungesättigten Ketons. |
| US2900382A (en) * | 1952-06-28 | 1959-08-18 | Syntex Sa | Method of making delta4,6 steroid compounds from delta4 steroid compounds |
| US2882282A (en) * | 1957-07-17 | 1959-04-14 | Pfizer & Co C | Method of producing 3-keto-delta4, 6-steroid compounds from 3-keto a-ring saturated 6-dihydro steroid compounds |
| US2891079A (en) * | 1959-01-23 | 1959-06-16 | Searle & Co | 6-methyl-4, 6-pregnadiene-3, 20-dione and 17alpha-acyloxy derivatives thereof |
-
1958
- 1958-11-04 GB GB35428/58A patent/GB870286A/en not_active Expired
-
1959
- 1959-10-27 US US848917A patent/US3356573A/en not_active Expired - Lifetime
- 1959-10-29 DE DEB55336A patent/DE1120446B/de active Pending
- 1959-11-02 FR FR809052A patent/FR1333711A/fr not_active Expired
- 1959-11-02 CH CH8015259A patent/CH379493A/de unknown
- 1959-11-04 BE BE584312A patent/BE584312A/fr unknown
-
1960
- 1960-08-31 FR FR837319A patent/FR970M/fr active Active
-
1964
- 1964-12-30 MY MY75/64A patent/MY6400075A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR1333711A (fr) | 1963-08-02 |
| GB870286A (en) | 1961-06-14 |
| US3356573A (en) | 1967-12-05 |
| DE1120446B (de) | 1961-12-28 |
| BE584312A (fr) | 1960-05-04 |
| CH379493A (de) | 1964-07-15 |
| MY6400075A (en) | 1964-12-31 |